Screening/baseline | Maternal Supplementation | |||
---|---|---|---|---|
Visit Timeframe | T1 | T2 | T3 | Birth |
Before 14 Wks. GA | 22–26 Wks. GA | 37–39 Wks. GA | 0 to 2 Wks. | |
Informed consent | X | |||
Randomization | X | |||
Maternal visual acuity and contrast sensitivity | X | X | X | X |
Maternal nutritional surveys | X | X | X | X |
Dilated eye examination | X | X | X | X |
Maternal serum carotenoids | X | X | X | X |
Maternal macular pigment imaging | X | X | X | X |
Maternal skin carotenoids | X | X | X | X |
Dispense prenatal supplement and do pill counts | X | X | X | X |
Infant cord blood carotenoids | X | |||
Infant macular pigment imaging | X | |||
Infant foveal imaging (SD-OCT) | X | |||
Infant skin carotenoids | X |